Healthcare Tomorrow: Pitching The Future

Every year, thousands of people have part of a damaged meniscus removed, and for many of them, the knee pain never really goes away. Today’s guest wants to change that. Maarten van der Zanden is CEO of Dutch startup ATRO Medical, which is developing a clinical-stage artificial meniscus for patients still struggling after surgery. He joins us to talk about the technology, and the wider impact it could have on patients, on surgeons, and on the future of orthopaedic care…

Today, we’re talking about youth mental health. For 25 years, Kooth has been one of the UK’s best-known digital mental health services for young people, bringing together one-to-one chat with mental health professionals, self-guided tools and moderated peer support into one place. In supported areas it’s funded by the NHS, local councils and partners. That means no subscriptions and no waiting lists. Young people can get support on their own terms, whenever they need it. Kooth has grown enormously after launching alongside the NHS in 2001 - 20 million people now have access to a Kooth service across the UK and US. As Kooth celebrates its 25th anniversary, this is a real inflection point for the company. Not only is Kooth launching an evolved digital platform - Soluna - but young people, mental health and the impact of technology are at the centre of political and social debate.  To find out more, we’re joined by Lynne Green, Chief Clinical Officer at Kooth... 

Today, we’re talking about stress and the toll it takes on our long-term health. Chronic stress is closely linked to many of the conditions putting the most pressure on health systems. Yet most of us have very little insight into how our bodies actually respond to stress day to day. That’s the gap Polsen Health set out to fill. The Amsterdam-based company has created what it calls the NOWATCH Awareable, a screenless wearable that doesn’t push scores or demand your attention. Its Reactivity Monitor captures heart rate, motion and skin activity every second to track how long stress lasts, how quickly you recover, and how often it strikes. When a stress response begins, the device gives a gentle nudge to pause before it escalates. So what was the spark behind NOWATCH? And could understanding stress be the key to genuinely preventive healthcare? Timothée Manschot, CEO and co-founder of Polsen Health explains more…

Medication non-adherence is one of the biggest issues in healthcare today - and one of the most overlooked. It contributes to an estimated 200,000 premature deaths every year. And it costs the EU up to €125 billion annually. Today, we're joined by Kieran Daly, General Manager and Co-Founder of HealthBeacon - the smart sharps bin innovators. His company is tackling this issue head-on, using smart technology to help patients manage their medications at home. Kieran is here today to explain how better adherence doesn't just save lives… It transforms the economics of care.

Today, we're joined by Dr. Salvatore Viscomi, CEO and co-founder of Carna Health. Carna is an AI-driven platform built to detect, manage, and prevent Cardio-Kidney-Metabolic syndrome. In just the past year, they've secured funding, landed a spot on Fortune's Most Innovative Companies list, and launched pilots reaching 35,000 people in Cameroon. Now they're expanding into the Democratic Republic of Congo and Southeast Asia, with a US launch on the horizon. Salvatore is here to share how they're scaling impact — one screening at a time.

Today, we're joined by Dr. Ryan Samuels, former NHS doctor and director at Eolas Medical. In high-pressure settings like a night shift, clinicians need critical information fast - but too often, they're searching through fragmented systems with little support. Eolas Medical’s AI-powered 'answer engine' is already used by 85% of acute trusts and more than 350,000 UK clinicians. Ryan’s here to reveal why clinical empathy and technical fluency matter just as much as the technology itself - and why he believes both have been overlooked in the rush to adopt AI…

Today, we're joined by Dr. Lara Zibners, co-founder and chair of Calla Lily Clinical Care, a clinical-stage company pioneering vaginal drug delivery, with applications spanning fertility, menopause, cancer, and infectious disease. Calla Lily has recently been selected for Wellcome Leap's $50 million Focused Antibiotics programme - targeting a UTI treatment that spares the gut microbiome. Lara is here to share why solving for women means solving for everybody, and how rethinking drug delivery - rather than chasing new molecules - could reshape the fight against antibiotic resistance…

As healthcare moves beyond the hospital, we’re connecting more devices than ever. But that connectivity brings a new challenge: how do you keep it secure and manageable at scale? Today, we’re joined by Colin Neale, Principal Business Development Manager at Wireless Logic. He’s here to tell us how real-time data from connected assets can help providers spot risks earlier and protect patient environments…